Why it matters now
The first test is whether Foundation Medicine changes what researchers, clinicians, builders or patients can decide with more confidence.
Foundation Medicine connects therapeutics company with evidence, methods and choices that shape modern biotechnology.
The open question for Foundation Medicine is how much of the promise survives contact with real data.
We follow the surrounding evidence: independent use, peer-reviewed data, instrument performance, commercial incentives and the practical barriers that slow adoption.
This page will remain useful as a reference point for readers comparing Foundation Medicine with neighboring tools, firms and methods in Drug Discovery.
The first test is whether Foundation Medicine changes what researchers, clinicians, builders or patients can decide with more confidence.
Important signals include independent replication, transparent endpoints, method details and use by groups outside the original sponsor.
The page returns to unresolved issues when new data, partnerships, filings, trials or technical documents change the picture.